Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
completed133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

NCT01565915
completednot_applicable

Safety/Efficacy Study of Restylane® in Lip Augmentation

NCT00935272
terminatednot_applicable

The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

NCT01224509

Clinical Trials (3)

Showing 3 of 3 trials
NCT01565915Not Applicable

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

Unknown
NCT00935272Not Applicable

Safety/Efficacy Study of Restylane® in Lip Augmentation

Completed
NCT01224509Not Applicable

The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

Terminated

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3